Drugs / Coumarin
last change Sep 2015 re-read 3 minutes ago

Coumarin

Small molecule

Developed for
chronic venous insufficiency
Investigated by
Takeda

Trials 1

201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 4 NCT01848210 May 2013 → Sep 2015 chronic venous insufficiency Takeda Completed Missed primary

Evidence & citations 14 cited values

Every value below carries the sentence it was read from. 2 sources stand behind the page.

FieldValueCited text
Known as Coumarin ClinicalTrials.gov intervention name — accepted as the source's own label NCT01848210 ↗
Known as 1,2-benzopyrone ChEMBL registry synonym — accepted as the source's own label CHEMBL6466 ↗
Known as Cis-o-coumarinic acid lactone ChEMBL registry synonym — accepted as the source's own label CHEMBL6466 ↗
Known as Coumarin (prohibited) ChEMBL registry synonym — accepted as the source's own label CHEMBL6466 ↗
Known as Coumarinic lactone ChEMBL registry synonym — accepted as the source's own label CHEMBL6466 ↗
Known as Coumarinum ChEMBL registry synonym — accepted as the source's own label CHEMBL6466 ↗
Known as Cumarin ChEMBL registry synonym — accepted as the source's own label CHEMBL6466 ↗
Known as Lodema ChEMBL registry synonym — accepted as the source's own label CHEMBL6466 ↗
Known as Nci-c07103 ChEMBL registry synonym — accepted as the source's own label CHEMBL6466 ↗
Known as NSC-8774 ChEMBL registry synonym — accepted as the source's own label CHEMBL6466 ↗
Known as O-hydroxycinnamic acid lactone ChEMBL registry synonym — accepted as the source's own label CHEMBL6466 ↗
Known as Tonka bean camphor ChEMBL registry synonym — accepted as the source's own label CHEMBL6466 ↗
Modality Small molecule — CHEMBL6466 ↗
Route Oral “Coumarin 30 mg, troxerutin 180 mg fixed-dose combination tablets, orally, three times daily for up to 16 weeks.” NCT01848210 ↗